Substituted indazole compounds as RORgammaT inhibitors and uses thereof
US10689369B2 · kind B2 · utility
0Cited by
52References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 18, 2019 |
| Grant date | Jun 23, 2020 |
| Priority date | — |
| Expiry date | Mar 18, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/107
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.